Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy
Pediatric high-grade glioma (pHGG) is the leading cause of cancer death in children. Despite histologic similarities, it has recently become apparent that this disease is molecularly distinct from its adult counterpart. Specific hallmark oncogenic histone mutations within pediatric malignant gliomas...
Main Authors: | Maya S. Graham, Ingo K. Mellinghoff |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/19/7193 |
Similar Items
-
Transcriptomic and epigenetic profiling of ‘diffuse midline gliomas, H3 K27M-mutant’ discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location
by: David Castel, et al.
Published: (2018-11-01) -
Diffuse midline glioma-H3K27M mutant. A novel entity with a defining and specific IHC marker
by: Prachi Agarwal, et al.
Published: (2021-01-01) -
Pediatric Diffuse Midline Gliomas H3 K27M-Mutant and Non-Histone Mutant Midline High-Grade Gliomas in Neurofibromatosis Type 1 in Comparison With Non-Syndromic Children: A Single-Center Pilot Study
by: Federica Garibotto, et al.
Published: (2020-06-01) -
Mosaic Pattern of H3 K27M-Mutant Protein Expression in a Diffuse Midline Glioma—A Diagnostic Dilemma for the Pathologist
by: Deepti Narasimhaiah, et al.
Published: (2021-05-01) -
A longitudinally extensive H3 K27M-mutant diffuse midline
glioma in an elderly patient clinically mimicking central nervous
system inflammation: a case report
by: Kristof Babarczy, et al.
Published: (2021-01-01)